Serotonin Has Nothing to Do With Happiness. Here Is What It Actually Does.
In a Nutshell
Cholestyramine, originally a cholesterol-lowering drug, binds bile acids to deplete liver cholesterol, upregulating the cholesterol synthesis pathway that also produces vital mitochondrial components coenzyme Q10 and heme A, enhancing energy production and aiding mold toxin removal. Unlike statins, it ramps up cholesterol synthesis, but requires gradual dosing to avoid acute deficits in cellular membranes and mitochondrial function. High-performers are prone to chronic illnesses like long COVID, Lyme, and mold due to stress-accelerated mitochondrial decline (1% yearly with age), which drains the body's energy budget and triggers repair failure cycles.
These notes were generated by AI and may contain inaccuracies.
Cholestyramine was originally a cholesterol-lowering drug used in the 1984 clinical trial considered proof that cholesterol causes heart disease. It works by binding bile acids and causing their excretion. Bile acids are made from cholesterol, so when bile acids are removed, the liver lacks cholesterol and takes it from the blood while increasing its own synthesis. Unlike statins, cholestyramine ramps up the liver's cholesterol synthesis.
Speaker built a mold filter 20 years ago using a 25-inch box fan, MERV 11 filter from Home Depot, and packing tape, based on Shoemaker's books. In the cholesterol synthesis pathway, two essential mitochondrial components are produced: coenzyme Q10 and heme A (component of the last mitochondrial engine for ATP production). Cholestyramine helps remove mycotoxins (mitochondrial toxins) per Shoemaker, but also boosts these mitochondrial components independently by upregulating the pathway.
The cholesterol synthesis pathway has 30-40 steps with branches producing multiple products, including cholesterol, coenzyme Q10, and heme A. Drugs act early in the pathway, affecting all downstream products. Depleting cholesterol prompts the liver to ramp up the pathway (increasing those products) and pull cholesterol from blood. The 1984 trial focused on blood cholesterol reduction; Shoemaker on toxin excretion via bile; additionally, it improves mitochondrial machinery.
Starting full dose of cholestyramine triggered mold illness symptoms, requiring slow ramp-up. Mold theory: reexposure to toxins. Alternative: initial cholesterol deficit flattened cellular function before liver adapted. Cholesterol is key for cellular membranes, including mitochondria. Acute deficit depletes liver cholesterol for bile replacement before pathways ramp up, necessitating gradual dosing.
Speaker tried cholestyramine for dad with CIRS, highly sensitive to mold buildings.
High-performers (e.g., celebrities) susceptible to long COVID, Lyme, mold due to stress-induced mitochondrial dysfunction and burnout. Mitochondria decline ~1% per year with age, driving aging.
Mitochondria fuel body production, maintenance, repair, distribution—including their own. They operate on an energy budget. Insults (COVID, Lyme, injuries, trauma) drain it, requiring rest/recovery to avoid deficit. Normal aging: daily 1% shortfall in maintenance leads to vicious cycle. High-performers skipping rest accelerate deficits, pushing into early mitochondrial repair failure cycles.
Keep Mikhaila Peterson in your library
Save the videos and channels worth coming back to, and find them again in one place.
